Low-cost, high-throughput quantitative phase microscopy
This project aims to develop a low-cost high-content screening platform using novel imaging technology to democratize access to advanced research tools in life sciences.
Projectdetails
Introduction
High-content screening is rapidly gaining traction across the biological sciences as a means to acquire more detailed data and test more hypotheses in an unprecedentedly rapid and systematic manner. However, a key issue identified by its users is that the instrumentation costs are too high, with systems typically costing from 150,000 to 800,000. This limits ownership of the instruments to well-funded research labs and, in doing so, excludes a significant portion of the multi-billion USD potential market. This project aims to target this unserved lower end of the market with a competitive high-content screening platform costing just 10,000.
Methodology
To achieve this, we will employ a novel quantitative phase imaging method originally developed for x-ray imaging as part of an ERC Starting Grant. The method allows us to make microscopes much simpler and less expensive without sacrificing image quality.
So far, we have successfully demonstrated that our new imaging approach is fast, robust, and can be readily utilized in such a low-cost screening system. Moreover, our IP is novel, protectable, and in the process of being patented.
Development Plan
This project will take the next steps towards commercialization by:
- Developing our prototype into a minimum viable product.
- Carrying out extensive research into the market and customer base to determine the optimum price point.
- Developing a field-tested sales pipeline and revenue model.
- Creating a robust business plan for the eventual spinout company.
Risk Assessment
Our decision to pursue the market for low-cost devices carries significant risk in that it necessitates high market penetration to achieve sufficient sales volume. However, should we successfully mitigate this risk (e.g., via focused development of the sales strategy), our endeavor will:
- Eliminate the main entry barrier to high-throughput life science research.
- Empower a new demographic of users with cutting-edge research tools.
- Address the growing issue of inequality in research and healthcare.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 30-6-2024 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- DANMARKS TEKNISKE UNIVERSITETpenvoerder
- CLAIR SCIENTIFIC APS
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Next-gen fluorescence imaging for research and theranosticsThe project aims to develop the TriScanner, a novel fluorescence microscope that enhances imaging speed, resolution, and sensitivity for multicellular systems in research and clinical applications. | ERC Proof of... | € 150.000 | 2023 | Details |
Fast and simple biomarker detection by computational microscopyWe developed a fast, sensitive biomarker detection method for early diagnosis and monitoring of cancer treatments, aiming to improve patient outcomes through preventative diagnostics. | ERC Proof of... | € 150.000 | 2024 | Details |
Instrumented human stem cells to see more during high throughput screening in drugInstrumented human stem cells to see more during high throughput screening in drug discovery and regenerative medicineThe hiPSCmore project aims to engineer fluorescent sensors in human induced pluripotent stem cells to reduce costs and enhance high-throughput imaging for drug discovery and regenerative medicine. | ERC Proof of... | € 150.000 | 2024 | Details |
Advanced X-ray Energy-sensitive Microscopy for Virtual HistologyThis project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Multiplexed microRNA detection platform for early diagnosis and patient managementThe MiRACLE project aims to develop a cost-effective diagnostic platform for early disease detection by utilizing a novel optical sensing method to simultaneously detect individual micro-RNA molecules in bodily fluids. | ERC Proof of... | € 150.000 | 2024 | Details |
Next-gen fluorescence imaging for research and theranostics
The project aims to develop the TriScanner, a novel fluorescence microscope that enhances imaging speed, resolution, and sensitivity for multicellular systems in research and clinical applications.
Fast and simple biomarker detection by computational microscopy
We developed a fast, sensitive biomarker detection method for early diagnosis and monitoring of cancer treatments, aiming to improve patient outcomes through preventative diagnostics.
Instrumented human stem cells to see more during high throughput screening in drugInstrumented human stem cells to see more during high throughput screening in drug discovery and regenerative medicine
The hiPSCmore project aims to engineer fluorescent sensors in human induced pluripotent stem cells to reduce costs and enhance high-throughput imaging for drug discovery and regenerative medicine.
Advanced X-ray Energy-sensitive Microscopy for Virtual Histology
This project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions.
Multiplexed microRNA detection platform for early diagnosis and patient management
The MiRACLE project aims to develop a cost-effective diagnostic platform for early disease detection by utilizing a novel optical sensing method to simultaneously detect individual micro-RNA molecules in bodily fluids.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
High Throughput Cell contractility system for rapid drug evaluationCytocypher en Optics11 ontwikkelen samen een prototype van een high throughput screening systeem voor het functioneel meten van hartspiercellen, ter bevordering van cardiologisch onderzoek. | Mkb-innovati... | € 193.900 | 2015 | Details |
Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platformNanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs. | EIC Transition | € 2.489.571 | 2022 | Details |
Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platformThe NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology. | EIC Transition | € 2.489.162 | 2023 | Details |
BORSTKANKERDETECTIE D.M.V. CAMERATECHNOLOGIEËN/ ARTIFICIËLE INTELLIGENTIESigmascreening onderzoekt de haalbaarheid van een innovatief product voor borstkankerdetectie met 3D-camera's en AI, gericht op toegankelijkheid en marktbehoefte. | Mkb-innovati... | € 20.000 | 2020 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
High Throughput Cell contractility system for rapid drug evaluation
Cytocypher en Optics11 ontwikkelen samen een prototype van een high throughput screening systeem voor het functioneel meten van hartspiercellen, ter bevordering van cardiologisch onderzoek.
Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platform
NanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs.
Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platform
The NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology.
BORSTKANKERDETECTIE D.M.V. CAMERATECHNOLOGIEËN/ ARTIFICIËLE INTELLIGENTIE
Sigmascreening onderzoekt de haalbaarheid van een innovatief product voor borstkankerdetectie met 3D-camera's en AI, gericht op toegankelijkheid en marktbehoefte.
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.